GSA Capital Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
ACH
GSA Capital Partners's VCYT Position: Q2 2025 in Review
GSA Capital Partners sold out of Veracyte (VCYT) in Q2 2025, closing a stake of 41,432 shares — an estimated $1.23M sold.
GSA Capital Partners first reported a position in VCYT in Q4 2016 and held it in 15 quarters. The position peaked at $2.19M in Q1 2023. 278 funds tracked by Wall St. Rank hold VCYT as of Q2 2025.
- GSA Capital Partners reported no remaining Veracyte position as of Q2 2025 after selling out during the quarter.
- GSA Capital Partners sold 41,432 Veracyte shares in Q2 2025, an estimated $1.23M.
- GSA Capital Partners first reported a position in Veracyte in Q4 2016 and held it in 15 quarters.
- GSA Capital Partners's Veracyte position peaked at $2.19M in Q1 2023.
- 278 funds tracked by Wall St. Rank held Veracyte as of Q2 2025.
Based on GSA Capital Partners's 13F filing for Q2 2025, filed 22 Jul 2025.